This review highlights the association between left ventricular hypertrophy in hypertensive patients and increased risk of heart failure, ischemia, and sudden death, emphasizing the need for further research on pharmacological interventions.
Answers are grounded in this paper and cite their sources.
LVH in hypertension signals higher HF, ischemia, and sudden death risk; leaves open which pharmacological interventions best improve outcomes.
The presence of left ventricular hypertrophy in hypertensive patients has been linked with increased likelihood for developing congestive heart failure, the potential for myocardial ischemia and the inherent risk for sudden death. In this paper we review current knowledge regarding the role of left ventricular hypertrophy in cardiac morbidity and mortality and emphasize the need for further study to explore the efficacy of pharmaceutical agents in reducing cardiac complications of hypertension in high-risk patients.
No takes yet. Share an insight, caveat, or question.
Massie et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: